The problem
Many developing countries around the world do not have access to affordable, lifesaving medicines. Public health initiatives that increase competition, such as voluntary licensing, have brought about significant price reductions for medicines to treat HIV, tuberculosis (TB) and hepatitis C, but in some cases voluntary licenses may not grant access to all developing countries.
Download the project evaluation
Our response
This project promoted access to more affordable treatments in developing countries. ITPC worked with local civil society organizations and patient groups in different developing countries to overcome barriers to HIV, TB and hepatitis C medicines. ITPC capacitated and encouraged local stakeholders to use tools provided by national laws and international agreements to assure the quality of patents and increase the supply of generic medicines to reduce prices. ITPC also prepared the market for entry and uptake of optimized generic products.
